Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$9.3 - $18.27 $155,793 - $306,059
16,752 Added 34.73%
64,982 $630,000
Q2 2022

Aug 15, 2022

BUY
$11.79 - $27.63 $568,631 - $1.33 Million
48,230 New
48,230 $699,000
Q4 2021

Feb 14, 2022

SELL
$36.68 - $54.02 $386,350 - $568,992
-10,533 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$49.57 - $58.15 $23,397 - $27,446
472 Added 4.69%
10,533 $527,000
Q2 2021

Aug 16, 2021

BUY
$47.17 - $58.64 $221,887 - $275,842
4,704 Added 87.81%
10,061 $558,000
Q1 2021

May 17, 2021

SELL
$42.51 - $54.07 $565,425 - $719,185
-13,301 Reduced 71.29%
5,357 $251,000
Q4 2020

Feb 16, 2021

BUY
$31.9 - $44.89 $1,626 - $2,289
51 Added 0.27%
18,658 $812,000
Q3 2020

Nov 16, 2020

BUY
$28.55 - $36.91 $531,229 - $686,784
18,607 New
18,607 $681,000

Others Institutions Holding HCAT

About Health Catalyst, Inc.


  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $425M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.